Pfizer (NYSE:PFE) Shares Down 0.8% – What’s Next?

Pfizer (NYSE:PFE) - Stock Price, News & Analysis - Simply Wall St

Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

Pfizer (NYSE:PFE) Shares Down 0.8% – What’s Next?

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) fell 0.8% on Monday . The stock traded as low as $24.61 and last traded at $25.01. 12,092,606 shares were traded during trading, a decline of 69% from the average session volume of 38,933,814 shares. The stock had previously closed at $25.21. Wall Street Analysts Forecast […]

Rodgers Brothers Inc. Sells 1,075 Shares of Pfizer Inc. (NYSE:PFE)

Rodgers Brothers Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,303 shares of the biopharmaceutical company’s stock after selling 1,075 shares during the quarter. Rodgers Brothers Inc.’s holdings […]

Clifford Chance Advises Pfizer on US$3.3 billion Share Sale, Culmination of Four Transactions Totalling US$13.4 billion in Past 12 Months, Final Step in Pfizer Exiting its Investment in Haleon

The transaction completed on 21 March 2025 and forms part of a broader series of transactions through which Pfizer has now fully exited its investment in Haleon, a process that began in March 2024. In conjunction with this latest transaction, Haleon agreed to make an off-market purchase of approximately 44 million shares from Pfizer as part of an off-market share buyback programme agreed with Pfizer.Pfizer’s divestment from Haleon, implemented o…

Meridian Investment Counsel Inc. Acquires 2,137 Shares of Pfizer Inc. (NYSE:PFE)

Meridian Investment Counsel Inc. boosted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 65,157 shares of the biopharmaceutical company’s stock after buying an additional 2,137 shares during the quarter. Meridian Investment […]